RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 134 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,435 | -35.4% | 10,395 | -70.4% | 0.00% | – |
| Q1 2023 | $30,100 | +58.4% | 35,154 | +234.5% | 0.00% | – |
| Q2 2020 | $19,000 | +11.8% | 10,510 | 0.0% | 0.00% | – |
| Q1 2020 | $17,000 | -22.7% | 10,510 | +1.0% | 0.00% | – |
| Q4 2019 | $22,000 | +10.0% | 10,410 | -0.5% | 0.00% | – |
| Q3 2019 | $20,000 | -25.9% | 10,465 | 0.0% | 0.00% | – |
| Q2 2019 | $27,000 | -3.6% | 10,465 | -3.7% | 0.00% | – |
| Q1 2019 | $28,000 | +3.7% | 10,865 | -15.5% | 0.00% | – |
| Q4 2018 | $27,000 | -20.6% | 12,865 | +7.2% | 0.00% | – |
| Q3 2018 | $34,000 | +21.4% | 12,000 | +20.0% | 0.00% | – |
| Q2 2018 | $28,000 | -20.0% | 10,000 | 0.0% | 0.00% | – |
| Q1 2018 | $35,000 | -10.3% | 10,000 | -1.0% | 0.00% | – |
| Q4 2017 | $39,000 | +56.0% | 10,100 | +1.0% | 0.00% | – |
| Q3 2017 | $25,000 | -7.4% | 10,000 | 0.0% | 0.00% | – |
| Q2 2017 | $27,000 | -18.2% | 10,000 | 0.0% | 0.00% | – |
| Q1 2017 | $33,000 | +37.5% | 10,000 | 0.0% | 0.00% | – |
| Q4 2016 | $24,000 | -35.1% | 10,000 | 0.0% | 0.00% | – |
| Q3 2016 | $37,000 | +68.2% | 10,000 | 0.0% | 0.00% | – |
| Q2 2016 | $22,000 | +4.8% | 10,000 | 0.0% | 0.00% | – |
| Q1 2016 | $21,000 | -30.0% | 10,000 | 0.0% | 0.00% | – |
| Q4 2015 | $30,000 | +20.0% | 10,000 | 0.0% | 0.00% | – |
| Q3 2015 | $25,000 | -21.9% | 10,000 | 0.0% | 0.00% | -100.0% |
| Q2 2015 | $32,000 | -11.1% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $36,000 | +56.5% | 10,000 | 0.0% | 0.00% | – |
| Q4 2014 | $23,000 | +21.1% | 10,000 | 0.0% | 0.00% | – |
| Q3 2014 | $19,000 | -47.2% | 10,000 | 0.0% | 0.00% | -100.0% |
| Q2 2014 | $36,000 | -7.7% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $39,000 | +34.5% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $29,000 | -19.4% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $36,000 | +9.1% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $33,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 4,500,000 | $11,925,000 | 4.90% |
| HealthInvest Partners AB | 1,090,000 | $2,889,000 | 4.07% |
| GREAT POINT PARTNERS LLC | 5,000,000 | $13,250,000 | 2.94% |
| CM Management, LLC | 775,000 | $2,054,000 | 1.55% |
| SECTOR GAMMA AS | 1,469,604 | $3,894,000 | 0.92% |
| Sio Capital Management, LLC | 913,621 | $2,421,000 | 0.73% |
| Telemetry Investments, L.L.C. | 190,000 | $504,000 | 0.65% |
| DAFNA Capital Management LLC | 879,000 | $2,329,000 | 0.59% |
| Rock Springs Capital Management LP | 4,860,200 | $12,880,000 | 0.30% |
| Rhenman & Partners Asset Management AB | 1,520,000 | $4,074,000 | 0.27% |